Antimicrobial Resistance Art: Bridging Science and Health Through Visual Storytelling

By João L. Carapinha

April 9, 2026

antimicrobial resistance art

Antimicrobial resistance art is powerfully demonstrated in the illustrated album Sketching Antimicrobial Resistance: Thirty Stories, One Health, published in November 2025 by the EU-JAMRAI 2 initiative. The publication brings together 30 original artworks from artists across 30 European countries to make the complex phenomenon of antimicrobial resistance (AMR) accessible to wider audiences.

The art translates abstract scientific concepts into emotionally resonant visual stories using the One Health approach, which recognizes the interdependent health of humans, animals, and the environment. Rather than relying on alarmist messaging, antimicrobial resistance art emphasizes microbial ecology, resistance mechanisms, societal consequences, and practical behaviors that can preserve antimicrobial effectiveness.

Visualising Economic and Ecological Interdependence

The album’s most striking works transform AMR’s multisectoral impacts into memorable metaphors with clear relevance for health economics. One story highlights the €12 billion annual cost to European healthcare systems, while another notes 1.2 million global deaths per year, with projections reaching 39 million by 2050. Bulgarian artist Theodor Hristov’s “One Health World” depicts a giant human hand incorporating rivers, forests, farms and animals, showing how human decisions are inseparable from animal and environmental systems. Similarly, Croatian artist Anja Sušanj’s fractured snow globe illustrates how resistant organisms spread into even the most remote ecosystems.

Why Cultural Engagement Strengthens Antimicrobial Policy

By embedding rigorous data within pan-European artistic interpretation, this antimicrobial resistance art strengthens the health-economic case for investing in innovation, diagnostics and stewardship programmes. Its repeated emphasis on One Health interdependence challenges siloed budgets and calls for cross-sectoral funding models involving health, agriculture and environment ministries.

The album demonstrates how culturally attuned narratives can build public understanding and political willingness to protect the effectiveness of existing and future antimicrobials.

Reference url

Recent Posts

FDA Approval Lumvoa Therapeutics
FDA Approval Lumvoa Therapeutics Redefines Treatment Landscape for Thyroid Eye Disease

By João L. Carapinha

June 29, 2026

The FDA Approval Lumvoa Therapeutics delivers the first full insulin-like growth factor-1 receptor (IGF-1R) antagonist for thyroid eye disease (TED), a rare autoimmune condition that triggers orbital inflammation, proptosis, diplopia, pain, and risk of vision loss.
HIV Treatment Access
Public-Private Partnership Enhances HIV Treatment Access Through Innovative Drug Integration

By João L. Carapinha

June 29, 2026

A new agreement between Merck and the ADAP Crisis Task Force significantly advances HIV Treatment Access by integrating the newly approved single-tablet regimen IDVYNSO™ (doravirine/islatravir) into state AIDS Drug Assistance Programs that served more than 250,000 people with HIV in 2024.
EMA CHMP Meeting Highlights
Regulatory Insights from EMA CHMP Meeting Highlights

By HEOR Staff Writer

June 26, 2026

The EMA CHMP Meeting Highlights from 22-25 June 2026 show the committee advancing six new medicines while maintaining rigorous evidentiary standards for complex and rare conditions. Positive opinions covered an inactivated influenza vaccine for adults 50 and older, a levodopa-carbidopa intestinal...